Timothy Power | VP & Head, IR |
Giovanni Caforio | Chairman & CEO |
David Elkins | EVP & CFO |
Christopher Boerner | EVP & Chief Commercialization Officer |
Samit Hirawat | EVP & Chief Medical Officer, Global Drug Development |
Seamus Fernandez | Guggenheim Securities |
Christopher Schott | JPMorgan Chase & Co. |
Geoff Meacham | Bank of America Merrill Lynch |
Stephen Scala | Cowen and Company |
Chris Shibutani | Goldman Sachs Group |
Andrew Baum | Citigroup |
Aaron Gal | Sanford C. Bernstein & Co. |
Luisa Hector | Berenberg |
Evan Seigerman | BMO Capital Markets |
Carter Gould | Barclays Bank |
Matthew Phipps | William Blair & Company |
Charlie Yang | Morgan Stanley |
Dane Leone | Raymond James & Associates |
Good day, everyone, and welcome to the Bristol-Myers Squibb 2021 Fourth Quarter Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.